New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
February 18, 2014
09:04 EDTABBV, ENTAEnanta Pharmaceuticals could be acquired by AbbVie, says JMP Securities
Sterne Agee believes that coming HCV approvals could entice Abbvie (ABBV) to buy Enanta Pharmaceuticals (ENTA). The firm raised its price target on Enanta to $50 from $25 and recommends owning Enanta at current levels.
News For ENTA;ABBV From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
February 23, 2015
11:19 EDTENTA, ABBVEnanta announces JAMA publication of AbbVie VIEKIRA PAK study results
Subscribe for More Information
11:04 EDTABBVAbbVie reports VIEKIRA PAK HPV/HIV co-infection study results published
Subscribe for More Information
February 20, 2015
10:33 EDTABBVBattleground update: AbbVie named top global pick at Jefferies
Subscribe for More Information
07:23 EDTABBVAbbVie replaces Pfizer as top global pharma pick at Jefferies
Subscribe for More Information
February 19, 2015
12:13 EDTABBVAbbVie increases quarterly dividend 4% to 51c per share
Subscribe for More Information
February 17, 2015
18:06 EDTABBVPaulson & Co gives quarterly update on stakes
Subscribe for More Information
February 13, 2015
09:07 EDTABBVDeutsche Bank biotech analyst holds an analyst/industry conference call
Biotech Analyst Karnauksas discusses AbbVie's product pipeline in an Analyst/Industry conference call to be held on February 13 at 10 am.
06:13 EDTABBVShire says $1.6B break fee from AbbVie is not taxable, Financial Times reports
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use